Clinical Trials List
2010-11-01 - 2016-12-31
Phase III
Terminated3
ICD-10C56.1
Malignant neoplasm of right ovary
ICD-10C56.2
Malignant neoplasm of left ovary
ICD-10C56.9
Malignant neoplasm of unspecified ovary
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9183.0
Malignant neoplasm of ovary
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 陳祈安 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Shyen Yen Division of Obstetrics & Gynecology
- Peng-Hui Wang Division of Obstetrics & Gynecology
- 吳華席 Division of Obstetrics & Gynecology
- 劉希儒 Division of Obstetrics & Gynecology
- Huann-Cheng Horng Division of Obstetrics & Gynecology
- Yi-Jen Chen Division of Obstetrics & Gynecology
- 蔡曉文 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chyong-Huey Lai Division of Obstetrics & Gynecology
- Huei-Jean Huang Division of Obstetrics & Gynecology
- 邱健泰 Division of Obstetrics & Gynecology
- Ting-Chang Chang Division of Obstetrics & Gynecology
- Angel Chao Division of Obstetrics & Gynecology
- 饒玫珊 Division of Obstetrics & Gynecology
- 周宏學 Division of Obstetrics & Gynecology
- Cheng-Tao Lin Division of Obstetrics & Gynecology
- Tzu-I Wu Division of Obstetrics & Gynecology
- 黃寬仁 Division of Obstetrics & Gynecology
- Min-Yu Chen Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
1000 participants
